Ginkgo Bioworks‘ (NYSE: DNA) Datapoints arm, Tangible Scientific, and Inductive Bio today launched ADME-One, a single-SKU service that combines a Tier 1 ADME panel, AI-driven human pharmacokinetic projection, and compound management. It is the first product to come out of the three-way partnership the companies announced in August 2025, which committed them to a lab-in-the-loop workflow in which experimental ADME data flows back into Inductive’s models for retraining.
